EPISODE · Dec 21, 2011 · 6 MIN
A New Drug for ALS?
Merit Cudkowicz, MD, of Harvard Medical School, discusses the results of a phase 2 study—a reduction in functional decline and a significant drop in the death rate in those on the highest dose of the drug, dexpramipexole. See the Dec. 15 issue of Neurology Today for the full-text article: http://bit.ly/uqFbG7.
Embed this episode
NOW PLAYING
A New Drug for ALS?
0:00
6:58
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Neurology Now Podcast?
This episode is 6 minutes long.
When was this Neurology Now Podcast episode published?
This episode was published on December 21, 2011.
Can I download this Neurology Now Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!